Document is current
Any future updates will be listed below
-
Authors
Morak, Monika https://orcid.org/0000-0003-0809-8404
Pineda, Marta https://orcid.org/0000-0002-5403-5845
Martins, Alexandra https://orcid.org/0000-0003-4322-8497
Gaildrat, Pascaline
Tubeuf, Hélène
Drouet, Aurélie
Gómez, Carolina
Dámaso, Estela https://orcid.org/0000-0002-9650-7791
Schaefer, Kerstin
Steinke-Lange, Verena https://orcid.org/0000-0001-8491-3234
Koehler, Udo
Laner, Andreas https://orcid.org/0000-0003-4596-7293
Hauchard, Julie
Chauris, Karine
Holinski-Feder, Elke https://orcid.org/0000-0002-5172-2818
Capellá, Gabriel https://orcid.org/0000-0002-4669-7320
-
Funding
Funding for this research was provided by:
Fundació La Marató de TV3
Institut National Du Cancer
Association Nationale de la Recherche et de la Technologie
EC | European Regional Development Fund
Direction Générale de l’Offre des Soins (DGOS) Groupement des Entreprises Françaises dans la Lutte contre le Cancer (Gefluc) OpenHealth Institute
Deutsche Krebshilfe (111222)
Wilhelm Sander-Stiftung (2012.081.1)
- License Information
-
More Information
Article History
Received: 25 September 2021
Revised: 20 March 2022
Accepted: 11 April 2022
First Online: 9 June 2022
Competing interests
: All the authors declare: no support from any organization for the submitted work; GC has received personal fees from VCN Biosciences, outside the submitted work. H.T. was employed by Interactive Biosoftware for the time period October 2015-September 2018 in the context of a public-private PhD project partnership (CIFRE fellowship #2015/0335) between INSERM and Interactive Biosoftware. No potential conflicts of interest were declared by the other authors.
: Patients provided their informed consent compliant with the respective national ethical standards of Spain or Germany. Internal Ethics Committees approved this study.
